Clostridium difficile infection: epidemiology, risk factors and management (Q37814046)

23 August 2017

1 reference

title

Clostridium difficile infection: epidemiology, risk factors and management (English)

1 reference

23 August 2017

main subject

Clostridium difficile

0 references

author name string

Ashwin N Ananthakrishnan

series ordinal

1

1 reference

23 August 2017

language of work or name

English

0 references

publication date

30 November 2010

1 reference

Nature Reviews Gastroenterology & Hepatology

23 August 2017

published in

1 reference

23 August 2017

volume

8

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

17-26

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2010.190

23 August 2017

exact match

0 references

cites work

Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Clinical risk factors for severe Clostridium difficile-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing Clostridia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Clostridium difficile is no longer just a nosocomial infection or an infection of adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

The changing epidemiology of Clostridium difficile infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Clostridium difficile and inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Clinical recognition and diagnosis of Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Emergence of Clostridium difficile-associated disease in North America and Europe.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Clostridium difficile infection: new developments in epidemiology and pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

A case-control study of community-associated Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Review of current literature on the economic burden of Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Historical perspectives on studies of Clostridium difficile and C. difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Clostridium difficile toxins: mechanism of action and role in disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Processing of Clostridium difficile toxins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Isolation and characterisation of toxin A-negative, toxin B-positive Clostridium difficile in Dublin, Ireland

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

An epidemic, toxin gene-variant strain of Clostridium difficile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

The Vexed Relationship Between Clostridium Difficile and Inflammatory Bowel Disease: An Assessment of Carriage in an Outpatient Setting Among Patients in Remission

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Clinical practice. Antibiotic-associated diarrhea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Risk factors for Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Clostridium difficile 30 years on: what has, or has not, changed and why?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Evolving concepts in Clostridium difficile colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Binary toxin producing Clostridium difficile strains

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Measures to control and prevent Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Antimicrobial-associated risk factors for Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Renewed interest in a difficult disease: Clostridium difficile infections--epidemiology and current treatment strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Impact of Clostridium difficile on inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Risk factors for the development of fulminant Clostridium difficile colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Surgical aspects of fulminant Clostridium difficile colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Diagnosis and treatment of Clostridium difficile colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Clostridium difficile enteritis: an early postoperative complication in inflammatory bowel disease patients after colectomy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Clostridium difficile infection in patients with ileal pouch-anal anastomosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Diagnostic trends in Clostridium difficile detection in Finnish microbiology laboratories.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Treatment of Clostridium difficile infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Treatment of Clostridium difficile-associated disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Treatment of Clostridium difficile-associated disease: old therapies and new strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

A prospective study of risk factors and historical trends in metronidazole failure for Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

WITHDRAWN: In vitro activity of rifaximin and rifampin against clinical isolates of clostridium difficile in houston, texas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Meta-analysis to assess risk factors for recurrent Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Interruption of Recurrent Clostridium difficile-Associated Diarrhea Episodes by Serial Therapy with Vancomycin and Rifaximin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Treatment with monoclonal antibodies against Clostridium difficile toxins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Treatment with Monoclonal Antibodies againstClostridium difficileToxins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Clostridium difficile: controversies and approaches to management.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis: an observational study and review of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Infection control measures to limit the spread of Clostridium difficile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.190

Treatment with monoclonal antibodies against Clostridium difficile toxins

31 March 2020

1 reference

12 December 2020

Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee

1 reference

12 December 2020

Clostridium difficile-Associated Diarrhea and Colitis

1 reference

12 December 2020

Struggling with recurrent Clostridium difficile infections: is donor faeces the solution?

1 reference

12 December 2020

10.1038/NRGASTRO.2010.190

Identifiers

DOI

1 reference

23 August 2017

1 reference